|
|
|
|
|
Detail |
| hsa-miR-145 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
MicroRNA signatures in human ovarian cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Widespread deregulation of microRNA expression in human prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
MicroRNA gene expression deregulation in human breast cancer. |
2005 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. |
2006 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
High-throughput microRNAome analysis in human germ cell tumours. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
MicroRNA-143 and -145 in colon cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Reduced accumulation of specific microRNAs in colorectal neoplasia. |
2003 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. |
2007 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. |
2006 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
MicroRNA expression profiles in serous ovarian carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. |
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Diagnostic and prognostic microRNAs in stage II colon cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
MicroRNA profile analysis of human prostate cancers. |
2008 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
MicroRNA-regulated pathways associated with endometriosis. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Over- and under-expressed microRNAs in human colorectal cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Identification of novel microRNA targets based on microRNA signatures in bladder cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Microarray analysis of microRNA expression in renal clear cell carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Unspecified |
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation. |
2009 |
|
|
|
|
|
|